[go: up one dir, main page]

AR103810A1 - MODIFICATION OF HOSPEDANT CELL PROTEIN - Google Patents

MODIFICATION OF HOSPEDANT CELL PROTEIN

Info

Publication number
AR103810A1
AR103810A1 ARP160100522A ARP160100522A AR103810A1 AR 103810 A1 AR103810 A1 AR 103810A1 AR P160100522 A ARP160100522 A AR P160100522A AR P160100522 A ARP160100522 A AR P160100522A AR 103810 A1 AR103810 A1 AR 103810A1
Authority
AR
Argentina
Prior art keywords
protein
hospedant
modification
cell protein
host cell
Prior art date
Application number
ARP160100522A
Other languages
Spanish (es)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of AR103810A1 publication Critical patent/AR103810A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporcionan composiciones y métodos para líneas celulares diseñadas genéticamente y sistemas de expresión que permiten la expresión de proteínas recombinantes en células eucariotas y su facilidad de aislamiento. También se proporcionan sistemas de expresión celular capaces de expresar una proteína de interés esencialmente libre de una proteína de célula hospedante ligada. Reivindicación 14: La célula hospedante de acuerdo con cualquiera de las reivindicaciones 1 - 13, en donde la célula comprende un fragmento de la proteina PLBD2.Compositions and methods for genetically designed cell lines and expression systems that allow the expression of recombinant proteins in eukaryotic cells and their ease of isolation are provided. Cellular expression systems capable of expressing a protein of interest essentially free of a bound host cell protein are also provided. Claim 14: The host cell according to any one of claims 1-13, wherein the cell comprises a fragment of the PLBD2 protein.

ARP160100522A 2015-02-27 2016-02-29 MODIFICATION OF HOSPEDANT CELL PROTEIN AR103810A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562126213P 2015-02-27 2015-02-27

Publications (1)

Publication Number Publication Date
AR103810A1 true AR103810A1 (en) 2017-06-07

Family

ID=59255756

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100522A AR103810A1 (en) 2015-02-27 2016-02-29 MODIFICATION OF HOSPEDANT CELL PROTEIN

Country Status (1)

Country Link
AR (1) AR103810A1 (en)

Similar Documents

Publication Publication Date Title
EA201791918A1 (en) MODIFICATION OF PROTEINS OF CELL-OWNERS
MX382518B (en) CYTOMEGALOVIRUS ANTIGENS AND THEIR USE.
CY1121217T1 (en) METHODS FOR HARVESTING MAMMAL CELL CULTURES
IL286776A (en) Preparations and methods for preparing t cell preparations and their uses
CY1125392T1 (en) COMPOSITIONS AND METHODS OF PROTEINS
MX2022006513A (en) EXPRESSION CONSTRUCTS AND METHODS FOR GENETICALLY DESIGNING METHYLOTROPHIC YEAST.
MX2017011679A (en) Transposase polypeptides and uses thereof.
MX394528B (en) STEROIDS AND PROTEIN CONJUGATES THEREOF.
AR095437A1 (en) FUSION PROTEINS UNDERSTANDING UNION PDGF AND VEGF PORTIONS AND METHODS FOR USE
BR112019012343A2 (en) il-11ra antibodies
EP4368992A3 (en) Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue
MX383464B (en) ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS OF USING THE SAME.
CY1122701T1 (en) BACTERIA-BASED PROTEIN RELEASE
CL2019002605A1 (en) Formulations containing pd-1 binding proteins and methods of manufacturing the same.
AR094375A1 (en) METHODS OF USE OF CELLULAR CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE
BR112017023131A2 (en) anti-fnc antibodies
CU24405B1 (en) CRY1DA1 AMINO ACID SEQUENCE VARIATIONS PROTEINS FOR LEPIDOPTERS
MX2016009911A (en) OVERPRINTING OF REGULATORS OF THE N-GLYCOSILATION ROUTE TO MODULATE THE GLYCOSILATION OF RECOMBINANT PROTEINS.
PE20151774A1 (en) CONSTRUCTIONS OF MITOCHONDRIAL PROTEINS AND THEIR USES
MX2020001223A (en) TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS AND THEIR USE.
AR095268A1 (en) HUMAN ANTIBODIES THAT JOIN THE HUMAN NECROSIS FACTOR (TNF-a) AND METHODS TO PREPARE THEM
AR095199A1 (en) ANTI-CD52 ANTIBODIES
JOP20200329A1 (en) Immunodominant proteins and fragments in multiple sclerosis
AR112602A1 (en) ANTI-TrkB ANTIBODIES
IL284803A (en) Methods for the production of multimeric proteins in eukaryotic host cells

Legal Events

Date Code Title Description
FB Suspension of granting procedure